Fidson Healthcare Plc (FIDSON) – Strategy, SWOT and Corporate Finance Report

Fidson Healthcare Plc (FIDSON) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Fidson Healthcare Plc (Fidson) develops, manufactures and distributes prescription and over the counter (OTC) pharmaceutical products. The company offers various drug products and formulations for various therapeutic categories, namely, anti-infectives, cardio-vascular, anti-malaria, anti-fungal, antacid and antiulcer, cardiovascular, gastrointestinal, medicines for anxiety and sleep disorder, antidepressants, cough, cold, catarrh, allergies, multivitamins, herbal supplements, topical/dermatological medicines, anti-osteoarthritis and pain-relievers, among others. Its major products include antacid suspension classic, ctuxil, paracetamol, iprofloxacin, amino acid intravenous nutritional supplement, fluoxetine, and olanzapine. It markets products under brand names such as Gascol, Meprasil, Biosulin, Peflotab, Ciprotab, Cutenox and Peflotab, among others. The company has its manufacturing facility in Sango-Ota, Ogun State. Fidson is headquartered in Lagos, Nigeria.

Scope

• Detailed information on Fidson Healthcare Plc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Fidson Healthcare Plc in the form of a SWOT analysis

• An in-depth view of the business model of Fidson Healthcare Plc including a breakdown and examination of key business segments

• News about Fidson Healthcare Plc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Fidson Healthcare Plc and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Fidson Healthcare Plc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Fidson Healthcare Plcs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Swiss Pharma Nigeria Ltd

Famzy Nigeria Limited

May & Baker Nigeria PLC

Unique Pharmaceuticals Ltd

Glaxosmithkline Nigeria Limited

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Fidson Healthcare Plc - Key Facts

Fidson Healthcare Plc - Key Employees

Fidson Healthcare Plc - Key Employee Biographies

Fidson Healthcare Plc - Major Products and Services

Fidson Healthcare Plc - History

Fidson Healthcare Plc - Company Statement

Fidson Healthcare Plc - Locations And Subsidiaries

Head Office

Section 2 – Company Analysis

Company Overview

Fidson Healthcare Plc - Business Description

Business Segment: Consumer Products

Overview

Performance

Business Segment: Ethical Products

Overview

Performance

Business Segment: Over the Counter

Overview

Performance

Fidson Healthcare Plc - Corporate Strategy

Fidson Healthcare Plc - SWOT Analysis

SWOT Analysis - Overview

Fidson Healthcare Plc - Strengths

Fidson Healthcare Plc - Weaknesses

Fidson Healthcare Plc - Opportunities

Fidson Healthcare Plc - Threats

Fidson Healthcare Plc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Fidson Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Fidson Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Fidson Healthcare Plc, Recent Deals Summary

Section 5 – Company’s Recent Developments

Jul 18, 2022: Fidson introduces Aventra ProVision at NOA Conference, Abuja

May 30, 2022: Fidson strengthens relationships with physicians at NMA Conference

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Fidson Healthcare Plc, Key Facts

Fidson Healthcare Plc, Key Employees

Fidson Healthcare Plc, Key Employee Biographies

Fidson Healthcare Plc, Major Products and Services

Fidson Healthcare Plc, History

Fidson Healthcare Plc, Key Competitors

Fidson Healthcare Plc, Ratios based on current share price

Fidson Healthcare Plc, Annual Ratios

Fidson Healthcare Plc, Annual Ratios (Cont…1)

Fidson Healthcare Plc, Annual Ratios (Cont…2)

Fidson Healthcare Plc, Interim Ratios

Fidson Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Fidson Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Fidson Healthcare Plc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Fidson Healthcare Plc, Performance Chart (2018 – 2022)

Fidson Healthcare Plc, Ratio Charts

Fidson Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Fidson Healthcare Plc, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports